![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 13, 11432-11440, March 29, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
¶
From the
Department of Pathology, University of Oulu,
FIN-90014 Oulu, the § Thermo Labsystems OY, Laboratory
Technologies Division, FIN-00811, Helsinki, and the ¶ Department
of Pathology, University of Helsinki, FIN-00290 Helsinki, Finland
Received for publication, December 10, 2001, and in revised form, January 11, 2002
| |
ABSTRACT |
|---|
|
|
|---|
FAP52, a focal adhesion-associated
phosphoprotein, is a member of a FAP52/PACSIN/syndapin family of
proteins. They share a multidomain structure and are implicated in
actin-based and endocytotic functions. We show, by using both native
and recombinant proteins, that FAP52 selectively binds to the actin
cross-linking protein filamin (ABP-280). This was based on an affinity
purification followed by a sequence determination by mass spectrometry,
co-immunoprecipitation, overlay binding, and surface plasmon resonance
analysis. Binding studies with deletion mutants showed that the sites
of the interaction map to the highly FAP52 is a recently described focal adhesion-associated protein
which in immunofluorescence microscopy
(IFM)1 colocalizes with
vinculin, paxillin, and talin (1). The latter are well known focal
adhesion proteins that are also closely associated with the actin
cytoskeleton (2). More recently, two homologues of FAP52, PASCIN2 and
syndapin II, were identified (3, 4). They all share a modular structure
typified by a well conserved FER-CIP4 homology domain in the very N
terminus, followed by a highly In this study, we set out to identify binding partners of FAP52. A
single polypeptide band of 280 kDa was purified from cultured cells by
applying co-purification and co-immunoprecipitation techniques and, was
shown to be filamin (actin-binding protein, 280 kDa; ABP-280) by using
electrospray mass spectrometric analysis of tryptic peptides.
Interaction between FAP52 and filamin was further verified by using
direct binding assays. In IFM and immunoelectron microscopy (IEM) of
cultured cells, distinctly demarcated co-distribution of FAP52 and
filamin was seen at sites where the actin stress fibers abut the focal
adhesions. In cells overexpressing FAP52, a distinct reorganization of
actin and filamin was seen. On the basis of these results we suggest
that filamin serves as a link between FAP52 and the actin cytoskeleton
and that this interaction is important in linking focal adhesions to
actin cytoskeleton.
General Procedures--
The standard solutions, buffers, and
procedures for the purification and precipitation of DNA, restriction
enzyme digestions, ligation reactions, SDS-PAGE runs, and stainings
were as described in Sambrook et al. (6). DNA sequencing was
carried out on an automated ABI Prism 377XL DNA Sequencer (PerkinElmer
Life Sciences).
Materials--
Escherichia colistrain BL21(DE3) cells,
expression vectors pGEX-2T and pGEX-2TK, glutathione
(GSH)-Sepharose 4B, thrombin, Rainbow High Molecular Weight
Markers, and synthetic oligonucleotides were purchased from Amersham
Biosciences; isopropyl- Antibodies--
Rabbit polyclonal antibody to FAP52, denoted
Affi-K7, was produced and affinity-purified as described previously
(1). Mouse monoclonal anti-filamin antibody was obtained from Chemicon
International, Inc.; mouse monoclonal anti-GST and rabbit polyclonal
anti-HA epitope antibodies were from Santa Cruz Biotechnology;
rhodamine-phalloidin, Alexa Fluor 488 goat anti-rabbit IgG, and
Alexa Fluor 546 goat anti-mouse IgG were from Molecular Probes; mouse
monoclonal anti-paxillin antibody and rabbit anti-mouse IgG were from
Zymed Laboratories Inc.; and horseradish peroxidase
(HRP)-conjugated goat anti-rabbit IgG, HRP-conjugated goat anti-mouse
IgG, goat anti-rabbit IgG-agarose, and goat anti-mouse IgG-agarose were
purchased from Sigma. For IEM, protein A-gold particles
(diameter, 5 and 10 nm), prepared by Slot and Geuze (8), were used.
DNA Constructs and Protein Expression--
All the cDNA
constructs and the corresponding polypeptides were designated as
"FAP52" or "Fil" for FAP52 and filamin, respectively, followed
by the subscripted number of the first and the last amino acid (aa)
residue expressed.
Full-length FAP52 and its fragments were produced as fusion proteins
with glutathione S-transferase (GST) in BL21(DE3) cells by
employing the expression vectors pGEX-2T and pGEX-2TK. The 1.35-kb
cDNA encoding the full-length FAP52 was inserted into the
BamHI/EcoRI-cloning site in the vector as
described previously (1). For the cloning and expression of the 3'- and
5'-truncated mutants of FAP52, PCRs with the oligonucleotide primers
with add-on sequences for BamHI and EcoRI
restriction sites and the full-length cDNA of FAP52 as template
were utilized. The resulting cDNAs were cut with the matching
restriction enzymes and ligated to
BamHI/EcoRI-cut pGEX-2T or pGEX-2TK vectors.
For the production of the C-terminal fragments of filamin, pGEX-4T-1
vectors with the cDNAs encoding for the fragments Fil-(1524-2283), Fil-(2283-2490), and Fil-(2495-2647) were employed (a kind gift from
Dr. T. P. Stossel, Division of Hematology, Brigham and Women's Hospital, Boston (9)). Further C-terminal truncation mutants were
generated from the construct encoding for the fragment Fil-(1524-2283) by using a Site-directed Mutagenesis kit and oligonucleotide primers to
generate stop codons to appropriate sites of the cDNAs.
GST fusion proteins were expressed in E. coli BL21(DE3)
cells according to standard protocols, purified from the cell lysates on GSH-Sepharose 4B beads, and liberated from the beads by incubation with reduced GSH. For some experiments, FAP52 or its mutant form was
released from its fusion partner by incubation with thrombin. For the
control experiments, GST was expressed from the plasmid pGEX-2TK and
purified as above.
For the expression in cultured animal cells, cDNA constructs
encoding the full-length FAP52 or its fragments were produced by PCR
with engineered restriction sites. They were cut with EcoRI and EcoRV and subcloned into the
EcoRI/EcoRV-cloning site of pRK5 vector (a kind
gift from Dr. Joseph Schlessinger, New York University, Medical Center,
New York, NY). A hemagglutinin (HA) epitope tag was engineered to the C
terminus of the constructs by primer design. The following constructs
were generated: FAP52-HA (FAP52-(1-448) plus HA tag);
FAP52Nt-HA (FAP52-(1-293) plus HA tag); and
FAP52SH3-HA (FAP52-(390-448) plus HA tag).
Cell Cultures, Transfections, and Immunofluorescence
Microscopy--
Cultures of chicken embryo heart fibroblast (CEHF)
were established, and the cells were grown as described previously (1). HeLa cells were grown according to the same protocol with the exception
that Dulbecco's modified Eagle's medium was used. For transfections,
the cells were grown on glass coverslips to a confluence of 50-70%.
Transfections were carried out by using a FuGENE 6 transfection reagent
and following the manufacturer's instructions.
For IFM, CEHF cells grown on glass coverslips were fixed and stained
essentially as described (1). In cases with staining of actin
filaments, post-fixation was carried out with ethanol for 1 min. As
primary antibodies, Affi-K7 (rabbit), rabbit polyclonal anti-HA, mouse
monoclonal anti-filamin, or mouse monoclonal anti-paxillin were used at
appropriate dilutions. Fluorochrome-conjugated secondary antibodies or
phalloidin (Alexa Fluor 488 goat anti-rabbit IgG, Alexa Fluor 546 goat
anti-mouse IgG or rhodamine-phalloidin) were applied as secondary
antibodies. Viewing was under a Zeiss LSM510 laser scanning microscope
equipped with a Zeiss Axiovert 110M inverted microscope (Carl Zeiss
Microscopy). The images were processed by using an LSM
three-dimensional software, version 5.2 (Carl Zeiss Microscopy).
Immunoelectron Microscopy--
For IEM, CEHF-cells were grown
close to confluence. After washing with Hanks' salt solution and
fixation with 4% paraformaldehyde in phosphate-buffered saline (PBS)
containing 2.5% sucrose for 1 h, they were harvested with a cell
scraper and pelletted. The pellet was resuspended in 2.3 M
sucrose and frozen in liquid nitrogen. Cryosections (thickness 80 nm)
were cut by using a Leica Ultracut UCT microtome and placed on
Butvar-coated nickel grids. They were washed with PBS and blocked with
5% BSA with 0.1% ColdWaterFishSkin gelatin in PBS for 10 min.
For double labeling, the sections were first incubated with the
monoclonal mouse anti-filamin antibody in 0.1% BSA in PBS (BPBS) for
60 min, followed by an incubation with the rabbit anti-mouse IgG in
BPBS for 30 min, and with protein A-gold (diameter, 10 nm) in
BPBS for 30 min. Between each of these steps, the sections were washed
with PBS/glycine (6 times for 5 min). After this, the sections were
fixed in 1% glutaraldehyde in PBS and blocked with 1% BSA in
PBS/glycine for 30 min. They were then incubated with Affi-K7 followed
by protein A-gold (diameter, 5 nm), both in BPBS. Washings were
with PBS/glycine as above. The sections were then post-fixed in 2%
glutaraldehyde for 5 min, washed with PBS and distilled water,
counterstained with neutral 2% uranyl acetate for 5 min, and coated
with 1.8% methylcellulose with 0.3% uranyl acetate. The sections were
analyzed using a Philips 410 LS transmission electron microscope.
Preparation of Cell Lysates--
Whole-cell lysates were
prepared from the cells grown to confluence. They were first rinsed
with PBS and then scraped into a lysis buffer (50 mM Hepes,
pH 7.5, 150 mM NaCl, 1 mM EGTA, 10% glycerol,
1.5 mM MgCl2, 0.2 mM
Na3VO4, and 1% Triton X-100) supplemented with
protease inhibitors (0.1 µM aprotinin, 0.1 mM
leupeptin, 1 mM phenylmethylsulfonyl fluoride, and 5 mM benzamidine), and incubated in an ice bath for 20 min.
The lysates were cleared by centrifugation at 12,000 × g for 5 min at 4 °C.
Immunoprecipitation--
For immunoprecipitation (IP), Affi-K7
or anti-filamin antibodies were added to 500 µl of the cell lysate
(0.15 mg/ml). For control reactions, an equal volume of PBS was added
instead of the antibody. Then 50 µl of anti-rabbit IgG-agarose or
anti-mouse IgG-agarose, respectively, in PBS was added and incubated on
a nutator for 16 h at 4 °C. The beads were collected by
centrifuging at 500 × g for 2 min and then washing
three times with PBS. The volume was adjusted to 60 µl with PBS.
After addition of the Laemmli's sample buffer (15 µl) and boiling
for 2 min, the eluates were run on a 7.5 or 10% SDS-PAGE and then
analyzed by immunoblotting (IB).
Affinity Chromatography and Pull-down
Experiments--
Bacterially produced GST-FAP52 or GST was immobilized
on GSH-Sepharose 4B beads in PBS. The beads (25 µl) were incubated
with the CEHF lysate (0.15 mg of protein in 500 µl of lysis buffer) overnight at +4 °C on a nutator. They were then washed three times with PBS, and the volume was adjusted to 60 µl with PBS. After addition of 15 µl of a sample buffer and boiling, the proteins were
separated on a 7.5% SDS-PAGE gel which was then stained with Coomassie
Brilliant Blue (CBB).
For the pull-down experiments, 5 µg of the GST fusions of fragments
of FAP52 or filamin were immobilized on 20 µl of GSH-Sepharose 4B
beads in Tris-buffered saline (TBS). Twenty µg of the chicken gizzard
filamin or the bacterially produced FAP52, respectively, in 500 µl of
TBS was added, and the mixture was then incubated for 2 h at
+4 °C on a nutator. The beads were washed three times with TBS and,
after addition of 20 µl of a sample buffer, subjected to SDS-PAGE
separation, followed by IB with mouse anti-filamin or Affi-K7, respectively.
Immunoblotting--
For IB, the electrophoretically separated
proteins were transferred to NC membranes that were then blocked in 3%
nonfat dried milk powder in TBS. Thereafter, the filters were incubated
with Affi-K7 or mouse anti-filamin for 1 h at room temperature
(RT). After an overnight washing with TBS at RT, the filters were
incubated either with the HRP-conjugated goat anti-rabbit IgG or the
HRP-conjugated goat anti-mouse IgG, respectively. After a 5-h washing
with TBS, the blot was developed by the ECL method as described
previously (1).
Blot Overlay Assay--
For blot OL assays, bacterially produced
FAP52 and GST or GST fusions of filamin mutants were separated on
SDS-PAGE and transferred to NC membranes. The filters were blocked by
incubating with 3% nonfat dried milk powder in TBS overnight at
4 °C or for 2 h at RT, and then incubated with the purified
filamin or recombinant FAP52 in 1% nonfat dried milk powder in TBS for
overnight at 4 °C. For the visualization of the protein bands, the
overlays were washed with TBS for 3 h and then incubated with
either the mouse anti-filamin antibodies or Affi-K7, respectively, as
above, followed by an HRP-conjugated goat anti-mouse IgG or anti-rabbit
IgG, respectively. The blots were developed by using the ECL detection system.
Electrospray Ionization Mass Spectrometry--
For mass
spectrometry, pieces corresponding to the protein bands of interest
were excised from the CBB-stained polyacrylamide gels and processed as
described by Shevchenko et al. (10). Briefly, the proteins
were in gel-reduced, alkylated, and digested with trypsin at 37 °C.
The supernatant obtained was acidified with formic acid, loaded onto a
Poros R2 (Perspective Biosystems) microcolumn, and desalted according
to Gobom et al. (11). The peptides eluted with 40%
methanol, 5% formic acid were introduced into a nanoelectrospray needle (Protona). Nanoelectrospray tandem mass spectrometry was performed on an API III mass spectrometer (PerkinElmer Life Sciences) equipped with a nanoelectrospray source, as described elsewhere (12).
Surface Plasmon Resonance Analysis--
Surface plasmon
resonance (SPR) measurements were performed on a BIACORE 3000 analyzer
under a control of a BIACORE control software, version 3.1.1. (Biacore
AB). For experiments with the GST fusions of FAP52, of
Fil-(1524-2283), or mutants thereof as a ligand, anti-GST antibody
(Biacore AB) was immobilized on a carboxymethyl-coated CM5 sensor chip
by employing the GST capture and the amine coupling kits (Biacore AB).
Full-length GST-FAP52, or its mutants (0.15 mg/ml in 10 mM
sodium acetate, pH 5.5), or GST-Fil-(1524-2283), or its mutants (0.15 mg/ml in HBS-EP; 0.01 M Hepes, pH 7.4, 0.15 M
NaCl, 3 mM EDTA, 0.005% (v/v) polysorbate 20; Biacore AB),
were then injected onto the chip for 30 s with a flow rate of 30 µl/min. The chip was then equilibrated with HBS-EP.
For binding assays, chicken gizzard filamin or recombinant FAP52, both
in HBS-EP, were then passed over the chip at concentrations ranging
from 0 to 800 nM at a flow rate of 30 µl for 1 min for filamin or 3 min for FAP52. The binding of the analyte to the ligand
was detected from the change in the sensorgram. To correct the
sensorgram for a background binding and bulk refractive index changes,
a different flow cell without GST fusion protein was used as a
reference. As controls, GST-coated chips were used over which filamin
or FAP52 was passed at a concentration of 100 nM. Kinetics
was analyzed by BIAevaluation software, version 3.1.
Identification of Filamin as an FAP52-binding Protein--
To
identify binding partners of FAP52, we carried out IP experiments from
the lysates of cultured CEHF by using affinity-purified rabbit
anti-FAP52 antibodies (Affi-K7). IP followed by an SDS-PAGE and silver
staining revealed reproducibly a 280-kDa polypeptide band that was seen
in the experimental (Fig. 1A,
lane 2) but not in the control precipitations (Fig.
1A, lane 1). A band of a similar molecular weight
was also detected in the affinity binding ("pull-down") experiments
in which the cell lysate was passed over a column in which GST-FAP52
was coupled onto GSH-conjugated Sepharose beads (Fig. 1B,
lane 2). No such band was seen in control experiments with
GST-coated beads (Fig. 1B, lane 1). In
pull-down but not in IP experiments another prominent band of
about 220 kDa was seen.
The 280-kDa band was excised from the CBB-stained gel and subjected to
in-gel trypsin digestion. The extracted peptides then underwent
analysis by nanoelectrospray tandem mass spectrometry. The partial
primary structures of several peptides in the mass spectrum of the
280-kDa band were compared with the sequences in the data bases. In
five cases there was a match with GST, in four cases with FAP52, in one
case with myosin, and in one case with filamin (ABP-280 (13)). We also
analyzed the 220-kDa band seen in Fig. 1B. Five of seven
peptides showed a match with myosin heavy chain. We concluded that the
myosin sequence found among the peptides derived from the 280-kDa band
is actually originating from the more abundant material in the 220-kDa band.
Because the filamin-like sequence derived from the band that was not
seen in the controls and because the partial sequence and the molecular
weight of the band match with those of filamin, we decided to explore
the possibility of an interaction between filamin and FAP52. The
presence of FAP52, GST, and myosin sequences among the peptides derived
from the 280-kDa band was deemed unauthentic and was most probably due
to an abundance of these proteins in the type of experiments that were
carried out.
Association between Filamin and FAP52 in Cells in Vivo--
The
association between filamin and FAP52 was further explored by IP of
FAP52 from a lysate of CEHF cells and then analyzing the precipitate by
IB for coprecipitation of filamin. In a reciprocal experiment with
HA-tagged FAP52 (FAP52-HA)-transfected HeLa cells, anti-filamin
immunoprecipitate was analyzed for co-IP of FAP52-HA. As shown in Fig.
2A, filamin was present in the
precipitate obtained by using Affi-K7 but not in the control
precipitates (Fig. 2A, lanes 2 and 1,
respectively). On the other hand, FAP52-HA was seen in the anti-filamin
but not in the control immunoprecipitates (Fig. 2B,
lanes 2 and 1, respectively). These data show
that FAP52 and filamin co-immunoprecipitate from the cell lysates and
suggest that there could be a direct interaction between FAP52 and
filamin.
Demonstration of a Direct Interaction between FAP52 and
Filamin--
To determine whether the observed co-IP of FAP52 and
filamin is due to a direct interaction between them or is mediated by some other protein(s), we carried out direct binding assays. In OL
assay, bacterially produced FAP52 or GST fusions of the C-terminal fragments of filamin were run in SDS-PAGE, transferred to an NC membrane, and then overlaid with purified filamin or FAP52,
respectively, followed by an incubation with relevant antibodies and an
ECL detection. As seen in Fig.
3A, filamin binds to FAP52
(Fig. 3A, lane 2) but not to GST that was used as
a control (Fig. 3A, lane 1). In Fig.
3A, lanes 3 and 4, positions of GST
and FAP52, respectively, in a parallel SDS-PAGE, stained with CBB, are
shown.
In a reciprocal experiment, binding of FAP52 to filter-anchored filamin
was tested. For that purpose, bacterially produced C-terminal fragments
of filamin in the fusion with GST were used. In OL, binding of FAP52 is
seen to GST-Fil-(1524-2283) (Fig. 3B, lane 1)
but not to GST-Fil-(2283-2496) (lane 2) or to
GST-Fil-(2495-2647) (lane 3). In Fig. 3B,
lanes 4-6, a parallel SDS-PAGE run of the same fusion
proteins is shown. The polypeptides were transferred to NC filter and
visualized by the anti-GST antibody and the ECL detection system. These
data show that there is a direct interaction between FAP52 and filamin
and that in filamin the interaction site resides in the fragment
encompassing the residues 1524-2283.
The interaction between filamin and FAP52 was further explored by SPR
analysis. In these experiments, anti-GST antibody was immobilized on a
chip and used to capture the GST-FAP52 fusion protein. The sensorgram
(Fig. 3C) obtained upon injection of chicken gizzard filamin
at concentrations ranging from 0 to 800 nM onto the
GST-FAP52-coated chip shows a high affinity binding between filamin and
FAP52. The association and dissociation rate constants ka and kd were determined to be
1.06 × 105 M Mapping of the Interaction Site in FAP52--
Pull-down assay and
SPR were used to map the filamin-binding region in FAP52. For that
purpose, a large number of truncation mutants of FAP52 were expressed
as GST fusions in bacteria, purified, and used in the assays.
For the pull-down assays, GST-FAP52 or its mutants were immobilized on
GSH-Sepharose beads and incubated with chicken gizzard filamin. After
collecting and washing the beads, they were run on SDS-PAGE. The
electrophoretically separated proteins were then transferred to an NC
membrane, followed by an incubation with the mouse anti-filamin and the
ECL detection. Fig. 4A shows
that anti-filamin reactive material could be harvested not only from the beads carrying the full-length GST-FAP52 (lane 5) but
also those carrying the peptides 1-184, 1-219, and 1-359
(lanes 2-4). No binding of filamin was seen to beads
carrying the more N-terminal peptides 1-145 (lane 1) or the
C-terminal peptides 146-448, 185-448, 220-448, 281-448, 360-448,
and 390-448 (lanes 6-11).
For SPR analysis, the GST fusion of FAP52 or its mutants
were immobilized onto a sensor chip, and chicken gizzard filamin was
then passed over the chip at a concentration of 100 nM.
Fig. 4B shows that filamin binds to the GST-FAP52-(1-448)
and to the N-terminal peptides 1-184, 1-219, and 1-359. No binding
was observed to peptides 1-145, 146-448, 185-448, 220-448,
281-448, 360-448, or 390-448. Fig. 4C shows an SDS-PAGE
gel of the fusion proteins used in the experiments.
Both the OL and the SPR results indicated, in total conformity, that
the residues 146-184 have an essential role in the binding of filamin.
The capability of this region alone to bind filamin was tested with
SPR, in an experiment in which filamin was passed over the
GST-FAP52-(146-184)-coated chip. No binding was observed (Fig.
4B, inset). Thus, it can be concluded that the
region spanning aa 146-184 is necessary but not sufficient for the
binding of filamin. For the binding, a sequence N-terminal to the aa
145 is needed as indicated by binding with an N-terminal 1-184 peptide.
Mapping of the Interaction Site in Filamin--
The FAP52-binding
site in filamin was determined by pull-down
experiments and by SPR by employing sequentially
truncated mutants of the C-terminal half of filamin in fusion with
GST.
For the pull-down experiments, filamin mutants in fusion with GST were
immobilized onto the GSH-Sepharose beads which were then incubated with
the recombinant FAP52. Binding of FAP52 to the beads was analyzed by
SDS-PAGE followed by a transfer to an NC filter, IB with Affi-K7, and
ECL detection. Fig.
5A shows the binding of FAP52
to the filamin peptides 1524-1858, 1524-1956, 1524-2064, 1524-2132,
1524-2172, and 1524-2283 (lanes 3-8). There was no
binding of FAP52 to the peptides 1524-1780 and 1524-1664 (lanes
1 and 2).
For SPR analysis, GST-Fil-(1524-2283) or its truncated mutants were
captured onto the sensor chip, and the recombinant FAP52 was passed
over the chip. In Fig. 5B, binding of FAP52 to the truncated
filamins is shown. A strong binding is seen to the peptides 1524-1780,
1524-1858, 1524-1956, 1524-2064, 1524-2132, 1524-2172, and
1524-2283 and a weak binding to 1524-1664. In Fig. 5C,
SDS-PAGE analysis of the purified, bacterially produced GST fusions of the filamin fragments used in the assay is shown.
The results of the pull-down experiments suggest the residues
1780-1858, corresponding to the repeat 16, as the binding region for
FAP52. Closely similar binding data were obtained from the SPR
analysis, except that Fil-(1524-1780), which in the pull-down assay
did not bind FAP52, also showed a strong binding. The different binding
of Fil-(1524-1780) in the two assays is probably not due to
artifactual conformational changes because in both cases the filamin-GST chimera was anchored to the substrate via a linker (anti-GST antibody in SPR and GSH in pull-down assay). Rather, it may
reflect the different sensitivities of the techniques. The lacking or
low binding of Fil-(1524-1664) in both assays clearly indicates,
however, that the principal binding of FAP52 to filamin is in the
region aa 1664-1858 spanning the repeats 15-16.
Colocalization of FAP52 and Filamin in Cultured
Fibroblasts--
Biochemical studies described indicated a direct
interaction between FAP52 and filamin. Thus, it was expected that there
is at least a partial colocalization between FAP52 and filamin in cells
in vivo. This was studied by using a confocal laser scanning IFM and IEM. We applied double immunostaining with Affi-K7 and the
anti-filamin antibodies. Antibodies to focal adhesion protein paxillin
and a filamentous actin-binding compound phalloidin also were used for
comparative purposes.
Confocal IFM of well spread (Fig.
6A) and spreading CEHFs (Fig.
6B) showed that FAP52 is typically associated with the focal adhesions (verified by a double staining for paxillin; not shown) and
filamin along the actin fibers (verified by visualizing actin fibers
with phalloidin; not shown). At a closer scrutiny and in merged images,
distinct overlaps of the staining patterns could be seen. One was in
the areas where the filamin-decorated filaments merge with the focal
adhesions (Fig. 6A, arrows). The overlap area
seems to correspond to the more proximal part of the focal adhesion or
a putative "juncture" region in which the fibers are linked to the
focal adhesions. Another distinct overlap was seen in the spreading
cells with a smooth-contoured forward-moving front region (Fig.
6B, arrow). In them, in addition to the focal adhesion structures, a distinct colocalization was seen in distinct spots that were located at regular intervals along the very edge of the
cell (Fig. 6B, arrowheads).
Immunoelectron Microscopy--
Fig.
7 is an electron micrograph of a
cryosection of cultured CEHFs. The sections were double-stained with
antibodies to FAP52 and filamin. The localization of the bound
antibodies was revealed by secondary antibodies conjugated to small
(inner diameter, 5 nm) and large (inner diameter, 10 nm) gold
particles, respectively. The larger particles were seen most
prominently along filamentous structures that could be discerned even
though the overall contrast after uranyl staining was quite low (Fig.
7, arrows). The smaller particles, corresponding to FAP52,
on the other hand, were only seen in the peripheral parts of the cells,
and especially in elongated structures which, by their morphology and
localization, represent focal adhesions (Fig. 7,
arrowheads). In Fig. 7, B and C, which represent higher magnifications of the areas indicated by rectangles in
Fig. 7A, a colocalization of FAP52 (smaller
particles) and filamin (larger particles) was seen
(circled areas). Interestingly, the gold particles were
often linearly arranged, strongly suggesting that they are associated
with an underlying filamentous structure (Fig. 7, B and
C, bar-ended arrows).
Rearrangement of Actin and Filamin Cytoskeleton in Cells
Overexpressing FAP52--
Direct interaction between FAP52 and
filamin, as shown by biochemical techniques, and a close colocalization
between FAP52 and filamin, as shown by confocal microscopy and IEM,
prompted us to study the changes in the distribution of filamin in
cells overexpressing FAP52 or its specific regions/domains. Due to the actin cross-linking properties of filamin, the effect of the forced expression of FAP52 on the organization of actin cytoskeleton was also
investigated. For these purposes, confocal microscopy of CEHFs
transiently transfected either with HA-tagged FAP52 (FAP52-HA) or its
truncated forms was used. Double staining with appropriate antibodies
and phalloidin was used to analyze the distributions of FAP52-HA,
filamin, and actin.
A typically elongated or polygonal fibroblastic morphology was seen in
most naive (untransfected) CEHF cells (Fig.
8A, arrows). Cells
overexpressing HA-FAP52, on the other hand, displayed several types of
abnormal morphologies. Some of them were overly elongated and showed
several cell surface protrusions (Fig. 8A,
arrowheads). More typical were cells with an outlook
suggesting abnormal or arrested spreading (Fig. 8B). In some
cells, prominent ruffling edge-type formations were seen (Fig. 8,
C and D, arrows). A co-accumulation of
actin and FAP52 was also seen in the ruffling edge formations (Fig. 8,
C and D).
In most transfectants, a distinctly abnormal filamin distribution was
seen; instead of a linear organization along actin fibers, numerous
dot-like densities were seen especially close to the cell surface
(Fig. 8B, red). Almost invariably, the
dots also contained FAP52 (Fig. 8B, green).
Instead of stress fibers, only thin and shorter filaments were seen
running from one dot to another. This was also seen in double staining
with phalloidin; actin was only seen as distinct dots that also
contained FAP52 and as thin filaments interconnecting the dots as a
meshwork (Fig. 8D).
We also carried out transfection experiments using the HA-tagged
N-terminal peptide of FAP52 (aa 1-293; FAP52Nt-HA)
encompassing the filamin-binding site. For the most part similar
changes in actin and filamin organization were seen as with the
overexpression of the full-length protein. A specific change seen with
the N-terminal peptide was, however, the presence of transfectants with
numerous and often very long filopodial extensions on the cell surface (Fig. 8, E and F). In more quantitative terms,
the proportion of the cells with numerous filopodia was 30% in
untransfected cells and 60 and 64% in FAP52-HA- and
FAP52Nt-HA-transfected cells, respectively, with cells with
very long extensions (which were sometimes severed from the cell body;
Fig. 8F, arrow) seen exclusively in
FAP52Nt-HA transfectants. No major changes were seen upon
transfection with the constructs encoding the SH3 domain of FAP52 (not shown).
Due to the presence of FAP52 in the focal adhesions in naive cells, we
also wanted to see what happens to focal adhesions in cells
overexpressing FAP52-HA or FAP52Nt-HA. Surprisingly, even
in cells in which there were major distortions of the cell morphology
and actin network, there were still distinct focal adhesions to be seen
as revealed by a staining with anti-paxillin. They were not normal,
however. Instead of a radially oriented axis and regular spacing, they
displayed a more haphazard orientation. In most cases they were also
smaller and fewer in number than their counterparts in the naive cells
(61 versus 40 focal adhesions per cell in nontransfected
versus transfected cells; n = 61 and 57, respectively; Fig. 8G).
Based on these studies, it is clear that the overexpression of the
full-length FAP52 and its N-terminal, filamin-binding site-containing peptide brings about major derangements of the actin/filamin
organization accompanied by unscheduled and exaggerated filopodia
formation and minor derangements in the focal adhesion formation and architecture.
In this study, we provide evidence that FAP52 binds filamin and
suggest that, via filamin, FAP52 is involved in the regulation of the
actin cytoskeleton. Filamin, as a putative ligand for FAP52, was
discovered and identified by using affinity purification and mass
spectrometry. An in vivo association between FAP52 and
filamin was verified by reciprocal co-IP studies, and a direct
interaction between the proteins was demonstrated by using blot OL
assays and SPR analysis. Also the results from the studies on the
distribution of FAP52 and filamin in cultured cells are consistent with
an interaction between the proteins. Confocal microscopy of the cells overexpressing FAP52 or its filamin binding fragments also showed that
an aberrant expression of FAP52 leads to a gross derangement of the
actin cytoskeleton organization. This is taken as evidence that FAP52,
via its interaction with filamin, is involved in the regulation of the
actin cytoskeleton organization.
Filamin emerged as a putative binding partner of FAP52 from a pull-down
experiment employing GST-FAP52 and from co-IP experiments from the
solute of cultured fibroblasts. Positive identification was
based on a direct sequencing of the 280-kDa band that was repeatedly
seen in the pull-down experiments. Occasionally, also a smaller band of
about 220 kDa was seen which turned out to be heavy chain of myosin. In
subsequent studies we were, however, unable to demonstrate a direct
interaction between myosin and FAP52. This observation implies that
FAP52 could be involved in a multimolecular complex also encompassing myosin.
Filamin is an actin cross-linking protein and is involved in the
maintenance of the cytoskeletal architecture and in the adhesion and
migration of cells (14). Most of the protein, which occurs as a dimer,
is composed of 23 ~96-aa long repeats. They are flanked by an
N-terminal actin-binding domain and a C-terminal homodimerization domain which both are important for the organization of the cortical actin network (14, 15). They determine the capacity of filamin to
direct the positioning of actin and to form orthogonal actin/filamin networks (13, 16). Filamin is a multifunctional protein, and a great
number of proteins binding to its repeat domains have been described.
Most of them are either receptors or signaling proteins and are thought
to be involved in synchronizing cell surface events with changes in the
cytoskeletal architecture (14, 17). Especially pertinent in regard to
the present study is a binding of filamin to some integrins that are
closely linked both to cell adhesion and actin organization. Thus,
filamin binds to the cytoplasmic tail of integrin
In cultured fibroblasts, FAP52 is seen in focal adhesions where it
colocalizes with paxillin, talin, and vinculin (1). It is a
phosphoprotein, being phosphorylated on serine but not on threonine or
tyrosine residues. Up until now, no "ligands" for FAP52 have been
described. FAP52 has a distinctly multidomain structure. In the
N-terminal part, encompassing the aa residues 1-145, there is a
FER-CIP4 homology domain (22) and, encompassing aa residues 146-280, a
highly The putative binding site for filamin, as shown by the OL and SPR
assays employing truncated FAP52, resides in the N-terminal half of the
protein with the region spanning from aa 146 to 185 as its
indispensable estate. Interestingly, in the secondary structure prediction analysis, this region shows a high degree of In filamin, the binding site for FAP52 was localized to the region of
aa 1524-1858. This area corresponds to the repeats 14-16 and the
calpain-sensitive hinge region 1. Importantly, binding of furin (23),
tumor necrosis factor receptor-associated factor 2 (17), dopamine
D-receptor (24, 25), and calcium-sensing receptor (26, 27) have been
localized to the same area. Among some other filamin-binding proteins,
GpIb In cultured fibroblasts filamin is mostly seen associated with the
stress fibers (32, 33). FAP52, on the other hand, is associated with
the focal adhesions. In double staining experiments they mostly showed
a complementary pattern in that FAP52 was seen in the focal adhesions
where actin filaments abut head on. At a close examination and in
merged images it was obvious, however, that at the juncture of the
focal adhesions and the microfilaments, there is an area where the
distributions of FAP52 and filamin overlap. It was seen especially in
the focal adhesions in well spread and stationary cells. On the other
hand, there were also focal adhesions that did not show any distinct
overlap with filamin staining. This suggests that FAP52-filamin
association is only seen in structures representative of a certain
subclass of focal adhesions.
There are several detailed studies on the localization of filamin in
cultured cells at both the light and electron microscopic levels. Based
on them, filamin has been shown to be associated with stress fibers and
membrane ruffles (32, 34), microspikes (32), and in a delicate
actin-based subcortical net and polygonal actin filament nets (33). In
stress fibers, filamin is distributed in a discontinuous manner
("spotty" or "patchy") at shorter or longer intervals,
depending on the cell type (33, 35, 36).
The present results, based on a careful analysis of confocal
micrographs, clearly show that FAP52 is not only a focal
adhesion-associated protein but that it is also present in the juncture
area connecting focal adhesions and stress fibers and even to varying
lengths to the distal ends of stress fibers proper. This could be taken to implicate a "supportive" function in this hinge region to FAP52 and/or to the components to which it might bind. Given that there is a
juncture of some sorts between the focal adhesion and its abutting
stress fiber, it is reasonable to speculate that there are overlapping
elements that either guide the well orchestrated co-evolvement and/or
reinforce the structure of these two complex architectural
organizations. Interestingly, remarkably little is known about the
molecular mechanisms of the link between these two structures,
especially when compared with the detailed knowledge on the structure
and composition of the focal adhesions and stress fibers in separation.
The close association with filamin strongly suggests a role for FAP52
in the actin organization. This was clearly demonstrated by the
overexpression experiments in which major rearrangements of the actin
cytoskeleton were seen. They include the extensive filopodia formation
in response to an overexpression of the full-length FAP52 and an
emergence of a deranged net of actin fibers instead of stress fibers in
cells overexpressing the N-terminal domain of FAP52. In this respect,
it is interesting that an overexpression of the Ras-related small
GTPase RalA, which also binds filamin, elicits formation of filopodia
on the surfaces of the Swiss 3T3 cells and also recruits filamin to the
sites of filopod formation (9). These data along with the known
actin-organizing properties of the homologs of FAP52 point to the role
of FAP52, via its binding to filamin, as a major regulator of the actin cytoskeleton.
-helical N-terminal part of
FAP52 and to the C-terminal region of filamin, which also contains
binding sites to some transmembrane signaling proteins. In
immunofluorescence and immunoelectron microscopy of cultured
fibroblasts, a different overall subcellular distribution was seen for
filamin and FAP52 except for a stress fiber-focal adhesion junction
where they showed a notable overlap. Overexpression of the full-length
and mutant forms of FAP52 led to an extensive reorganization of actin
and filamin in cultured fibroblasts. Thus, the results show that FAP52 interacts with filamin, and we propose that this interaction is important in linking and coordinating the events between focal adhesions and the actin cytoskeleton.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical region, and a C-terminal Src
homology 3 (SH3) domain. In the middle, there is a "linker" region
that shows a high degree of sequence variation and does not conform to
any specific domain signature. Thus far, no specific function is
assigned to FAP52. PACSIN 2, its closest homologue, participates in the organization of the actin cytoskeleton and in the regulation of vesicular traffic (5). Syndapin II, on the other hand, along with other
syndapin isoforms, is involved in endocytosis and actin dynamics (4).
Both syndapin II and PACSIN 2 bind N-WASP, an important regulator of
actin cytoskeleton organization (4, 5). Thus, all the three members of
the family share a property of being closely associated with the actin
cytoskeleton-associated proteins or functions.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactopyranoside was from
MBI Fermentas; Site-directed Mutagenesis kit, Pfu
polymerase, and T4 DNA ligase were from Stratagene; restriction enzymes
were from MBI Fermentas and Promega Co., and chicken gizzard filamin was from Progen Biotechnik GmbH. For blot overlay (OL) assay, chicken
gizzard filamin was purified according to the method of Feramisco and
Burridge (7). HeLa cells were obtained from the American Type Culture
Collection; Immu-Mount mounting medium was from Shandon, Inc.; FuGENE 6 transfection reagent, reduced GSH, protease inhibitors aprotinin,
leupeptin, and phenylmethylsulfonyl fluoride were from Roche Molecular
Biochemicals; ampicillin, bovine serum albumin (BSA), and benzamidine
were from Sigma; and Triton X-100 was from Merck. Cell culture media
and fetal calf serum were from HyClone Laboratories, Inc.; and
nitrocellulose (NC) membranes were from Schleicher & Schuell.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (34K):
[in a new window]
Fig. 1.
A polypeptide of 280-kDa
co-immunoprecipitates with FAP52 and binds to GST-FAP52 in affinity
column chromatography. A, SDS-PAGE of the Affi-K7
(lane 2) and control immunoprecipitates (lane 1)
from the CEHF extracts, visualized by silver staining.
B, SDS-PAGE of polypeptides from the extract of CEHF cells
bound to the GSH-Sepharose beads carrying GST-FAP52 (lane 2)
or, as a control, GST (lane 1), visualized by CBB staining.
On the left, the position of the molecular mass
marker of 220 kDa is shown.

View larger version (15K):
[in a new window]
Fig. 2.
Filamin co-immunoprecipitates with FAP52, and
in the reciprocal experiment HA-tagged FAP52 co-immunoprecipitates with
filamin. A, SDS-PAGE and IB with anti-filamin of the
extracts of CEHF incubated with either Affi-K7 (lane 2) or,
for a control reaction, PBS (lane 1), followed by
anti-rabbit IgG-agarose. B, SDS-PAGE and IB with
Affi-K7 of the extracts of HeLa-cells expressing FAP52-HA incubated
with either mouse anti-filamin (lane 2) antibodies or, for
control reaction, PBS (lane 1), followed by anti-mouse
IgG-agarose. The molecular mass markers are shown on the
left.

View larger version (20K):
[in a new window]
Fig. 3.
Filamin binds FAP52 in OL assay and in SPR
analysis. A, FAP52, derived from the bacterially
produced GST-FAP52 by a thrombin cleavage (lane 2), and, as
a control, bacterially produced GST (lane 1), were run on
12% SDS-PAGE, transferred to NC filter, and then overlaid with the
chicken gizzard filamin. Binding of filamin was probed with the
anti-filamin antibodies and the ECL detection system. The positions of
GST and FAP52 in a parallel, CBB-stained 12% SDS-PAGE gel are shown in
the lanes 3 and 4, respectively. B,
the bacterially produced truncation mutants of filamin in fusion with
GST were run on 10% SDS-PAGE and transferred to an NC filter. The
filter was then overlaid with the recombinant FAP52. The binding of
FAP52 was probed by incubating with Affi-K7 and by ECL detection. The
position of the same polypeptides (lanes 4-6, respectively)
in the filter is shown by parallel 10% SDS-PAGE and IB with the
anti-GST antibody followed by ECL detection system. Migration of the
molecular mass markers is shown on the left. C, SPR
analysis. GST-FAP52 was immobilized on a CM5 sensor chip, and chicken
gizzard filamin was passed over the chip in mobile phase at
concentrations ranging from 0 to 800 nM. Inset,
sensorgram of a control experiment with GST anchored to the chip.
Arrows indicate the beginning and the end of filamin
injection.
1
s
1 and 1.02 × 10
3 s
1,
respectively, yielding a dissociation rate constant
(KD = kd/ka)
of 9.64 × 10
9 M. No binding was
observed in the control experiments in which the GST-coated chip was
overlaid with filamin (Fig. 3C, inset).

View larger version (23K):
[in a new window]
Fig. 4.
Determination of the filamin-binding region
in FAP52 by pull-down experiments and SPR. A,
SDS-PAGE and IB with anti-filamin of the full-length and the mutant
FAP52 (as GST fusions)-coupled GSH-Sepharose beads that were incubated
with filamin. B, SPR analysis of a binding of filamin to the
anchored full-length and truncated FAP52 (GST fusions). Filamin was
passed over the chip at a concentration of 100 nM.
Inset, sensorgram of a control experiment with the GST
anchored to the chip. Arrows indicate the beginning and the
end of filamin injection. C, SDS-PAGE (12%) analysis
of the fusion proteins used in the pull-down experiments and SPR
analysis.

View larger version (23K):
[in a new window]
Fig. 5.
Determination of the FAP52-binding region in
filamin by pull-down experiments and SPR. A, SDS-PAGE
and IB with Affi-K7 of GSH-Sepharose beads coupled with the filamin
peptides and incubated with the recombinant FAP52. B, SPR
analysis of the binding of FAP52 to the anchored filamin peptides (GST
fusion) and GST. The recombinant FAP52 was passed over the chip at a
concentration of 100 nM. Arrows indicate the
beginning and the end of filamin injection. C, SDS-PAGE
(10%) analysis of the fusion proteins used in the pull-down
experiments and SPR analysis.

View larger version (71K):
[in a new window]
Fig. 6.
FAP52 and filamin
colocalize in cultured CEHFs. In double staining, FAP52
(green) shows a partial colocalization with filamin
(red). FAP52 is in the elongated focal adhesions, whereas
filamin is seen as filamentous structures. In the merged image, a
distinct overlap of the staining is seen in the area corresponding to
the centrally oriented part of the focal adhesions (arrows
and arrowheads). Bars, 10 µm.

View larger version (103K):
[in a new window]
Fig. 7.
Colocalization of FAP52 and filamin as
revealed by gold IEM of cryosections of cultured CEHF.
A, the large particles (filamin; arrows) are
localized in fibrous structures, whereas the small particles (FAP52;
arrowheads) are seen closer to the edges of the cells.
B and C, blowups of the rectangled
areas in A. A linear orientation of the particles is
clearly seen (shown by bar-ended arrows). In the
circled areas, close proximity of the large (filamin) and
the small particles (FAP52) is seen. Bars, 100 nm.

View larger version (50K):
[in a new window]
Fig. 8.
Double immunofluorescence microscopy shows an
altered cellular morphology and filamin, actin and focal adhesion
organization in cells overexpressing FAP52. A, some of
the transfected cells (arrowheads) exhibited an elongated
cell shape with cell surface protrusions. Expression of HA-tagged FAP52
(green) and filamin (red) was detected.
Untransfected cells are shown by arrows. B, an abnormal
dot-like staining for filamin (red) was seen in many of the
cells overexpressing FAP52. The dots also contain FAP52
(green), as seen in the merged image. C, a
ruffling edge-type staining (arrows) of some cells
overexpressing FAP52 (green). In the central part of the
cell, FAP52 forms a dot-like staining pattern. The dots are
distributed along the actin fibers (red), as seen in the
merged image. D, co-distribution of FAP52 (green)
and actin (red) in the areas of the ruffling edge formation
(arrows). E and F, cells
overexpressing FAP52Nt-HA (green) typically
exhibit, at their edges, long filopodia that are sometimes severed from
the cell body (F, arrow). G, the
cells overexpressing FAP52 (green) exhibit smaller and more
randomly localized focal adhesions (red) than naive cells.
Bars, 10 µm.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 (18), the domain that is responsible for the
focal adhesion targeting (19) and cytoskeletal linkage of the molecule.
It also binds to integrin
7 cytoplasmic domain (18). In
platelets, glycoprotein Ib-IX (GPIb-IX), the receptor for von
Willebrand factor, is constitutively associated with filamin (20).
Filamin also binds to the cytoplasmic tail of
2 integrin
close to the binding site of
-actinin, another actin
cytoskeleton-associated protein (21).
-helical region. In the C terminus, there is an SH3 domain.
In the middle part of the molecule, encompassing the aa residues
281-389, there is a flexible linker region that does not form any
recognizable fold (1).
-helicity and a propensity to a coiled-coil arrangement (1). In this respect it
seems to differ from the other known filamin-binding peptides which,
according to our own analysis (not shown), do not display any notable
-helicity. It is noteworthy, however, that there is no obvious
similarity between the filamin-binding regions of the various known
filamin ligands except for a cluster of charged residues which,
according to helical wheel analysis, could serve as a platform to
filamin binding in integrins and GpIb
(21). This variability, on the
other hand, is quite expected in the light of the scattered nature of
the binding sites in filamin.
binds to the repeats 17-19 (28, 29), SEK-1 to the repeats
21-23 (30), and presenilin-1 to the repeats 22-24 (31). Thus, it is
apparent that sufficient unique information resides in the repeats to
create specific binding sites for a number of proteins. Binding of
FAP52 close to the hinge region (between the repeats 15 and 16) could
affect the flexibility of the filamin dimer and thus could have an
effect on the overall organization of the filamin cross-linked actin network.
| |
ACKNOWLEDGEMENTS |
|---|
We thank the Bioanalytical Research Group (Dr. Matthias Wilm) at the EMBL for mass spectrometry analysis; Dr. Päivi Pirilä and Dr. Kalervo Hiltunen for advice and invaluable help with surface plasmon resonance analysis; and Marjaana Vuoristo, Marja Tolppanen, Marja-Liisa Martti, Tarja Piispanen, Anna-Liisa Oikarainen, and Hannu Wäänänen for skillful technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by the Finnish Academy and the Finnish Cancer Research Fund.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Pathology, University of Oulu, P. O. Box 5000 (Aapistie 5), FIN-90014, Oulu, Finland. Tel.: 358-8-5375950; Fax: 358-8-5375953; E-mail: lehto@csc.fi.
Published, JBC Papers in Press, January 14, 2002, DOI 10.1074/jbc.M111753200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: IFM, immunofluorescence microscopy; FAP52, focal adhesion protein, 52 kDa; ABP-280, actin-binding protein, 280 kDa; SH3, Src-homology 3; IEM, immunoelectron microscopy; OL, overlay; BSA, bovine serum albumin; NC, nitrocellulose; HRP, horseradish peroxidase; aa, amino acid(s); GST, glutathione S-transferase; HA, hemagglutinin; CEHF, chicken embryo heart fibroblast; RT, room temperature; PBS, phosphate-buffered saline; IP, immunoprecipitation; IB, immunoblotting; CBB, Coomassie Brilliant Blue; TBS, Tris-buffered saline, SPR, surface plasmon resonance; ECL, enhanced chemiluminescence.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Meriläinen, J.,
Lehto, V.-P.,
and Wasenius, V.-M.
(1997)
J. Biol. Chem.
272,
23278-23284 |
| 2. |
Critchley, D. R.
(2000)
Curr. Opin. Cell Biol.
12,
133-139[CrossRef][Medline]
[Order article via Infotrieve] |
| 3. |
Ritter, B.,
Modregger, J.,
Paulsson, M.,
and Plomann, M.
(1999)
FEBS Lett.
454,
356-362[CrossRef][Medline]
[Order article via Infotrieve] |
| 4. |
Qualmann, B.,
and Kelly, R. B.
(2000)
J. Cell Biol.
148,
1047-1062 |
| 5. |
Modregger, J.,
Ritter, B.,
Witter, B.,
Paulsson, M.,
and Plomann, M.
(2000)
J. Cell Sci.
113,
4511-4521[Abstract] |
| 6. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed , pp. 1.63-18.57, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 7. |
Feramisco, J. R.,
and Burridge, K.
(1980)
J. Biol. Chem.
255,
1194-1199 |
| 8. |
Slot, J. W.,
and Geuze, H. J.
(1985)
Eur. J. Cell Biol.
38,
87-93[Medline]
[Order article via Infotrieve] |
| 9. |
Ohta, Y.,
Suzuki, N.,
Nakamura, S.,
Hartwig, J. H.,
and Stossel, T. P.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2122-2128 |
| 10. |
Shevchenko, A.,
Jensen, O. N.,
Podtelejnikov, A. V.,
Sagliocco, F.,
Wilm, M.,
Vorm, O.,
Mortensen, P.,
Shevchenko, A.,
Boucherie, H.,
and Mann, M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
14440-14445 |
| 11. |
Gobom, J.,
Nordhoff, E.,
Mirgorodskaya, E.,
Ekman, R.,
and Roepstorff, P.
(1999)
J. Mass Spectrom.
34,
105-116[CrossRef][Medline]
[Order article via Infotrieve] |
| 12. |
Wilm, M.,
Shevchenko, A.,
Houthaeve, T.,
Breit, S.,
Schweigerer, L.,
Fotsis, T.,
and Mann, M.
(1996)
Nature
379,
466-469[CrossRef][Medline]
[Order article via Infotrieve] |
| 13. |
Gorlin, J. B.,
Yamin, R.,
Egan, S.,
Stewart, M.,
Stossel, T. P.,
Kwiatkowski, D. J.,
and Hartwig, J. H.
(1990)
J. Cell Biol.
111,
1089-1105 |
| 14. |
Stossel, T. P.,
Condeelis, J.,
Cooley, L.,
Hartwig, J. H.,
Noegel, A.,
Schleicher, M.,
and Shapiro, S. S.
(2001)
Nat. Rev. Mol. Cell Biol.
2,
138-145[CrossRef][Medline]
[Order article via Infotrieve] |
| 15. |
Weihing, R. R.
(1985)
Can. J. Biochem. Cell Biol.
63,
397-413[Medline]
[Order article via Infotrieve] |
| 16. |
Cunningham, C. C.,
Gorlin, J. B.,
Kwiatkowski, D. J.,
Hartwig, J. H.,
Janmey, P. A.,
Byers, H. R.,
and Stossel, T. P.
(1992)
Science
255,
325-327 |
| 17. |
Leonardi, A.,
Ellinger-Ziegelbauer, H.,
Franzoso, G.,
Brown, K.,
and Siebenlist, U.
(2000)
J. Biol. Chem.
275,
271-278 |
| 18. |
Pfaff, M.,
Liu, S.,
Erle, D. J.,
and Ginsberg, M. H.
(1998)
J. Biol. Chem.
273,
6104-6109 |
| 19. |
Ylänne, J.,
Chen, Y.,
O'Toole, T. E.,
Loftus, J. C.,
Takada, Y.,
and Ginsberg, M. H.
(1993)
J. Cell Biol.
122,
223-233 |
| 20. |
Andrews, R. K.,
and Fox, J. E.
(1991)
J. Biol. Chem.
266,
7144-7147 |
| 21. |
Sharma, C. P.,
Ezzell, R. M.,
and Arnaout, M. A.
(1995)
J. Immunol.
154,
3461-3470[Abstract] |
| 22. |
Aspenström, P.
(1997)
Curr. Biol.
7,
479-487[CrossRef][Medline]
[Order article via Infotrieve] |
| 23. |
Liu, G.,
Thomas, L.,
Warren, R. A.,
Enns, C. A.,
Cunningham, C. C.,
Hartwig, J. H.,
and Thomas, G.
(1997)
J. Cell Biol.
139,
1719-1733 |
| 24. |
Li, M.,
Bermak, J. C.,
Wang, Z. W.,
and Zhou, Q. Y.
(2000)
Mol. Pharmacol.
57,
446-452 |
| 25. |
Lin, R.,
Karpa, K.,
Kabbani, N.,
Goldman-Rakic, P.,
and Levenson, R.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
5258-5263 |
| 26. |
Awata, H.,
Huang, C.,
Handlogten, M. E.,
and Miller, R. T.
(2001)
J. Biol. Chem.
276,
34871-34879 |
| 27. |
Hjalm, G.,
MacLeod, J.,
Kifor, O.,
Chattopadhyay, N.,
and Brown, E. M.
(2001)
J. Biol. Chem.
276,
34880-34887 |
| 28. |
Meyer, S. C.,
Zuerbig, S.,
Cunningham, C. C.,
Hartwig, J. H.,
Bissell, T.,
Gardner, K.,
and Fox, J. E.
(1997)
J. Biol. Chem.
272,
2914-2919 |
| 29. |
Takafuta, T., Wu, G.,
Murphy, G. F.,
and Shapiro, S. S.
(1998)
J. Biol. Chem.
273,
17531-17538 |
| 30. |
Marti, A.,
Luo, Z.,
Cunningham, C. C.,
Ohta, Y.,
Hartwig, J. H.,
Stossel, T. P.,
Kyriakis, J. M.,
and Avruch, J.
(1997)
J. Biol. Chem.
272,
2620-2628 |
| 31. |
Zhang, W.,
Han, S. W.,
McKeel, D. W.,
Goate, A.,
and Wu, J. Y.
(1998)
J. Neurosci.
18,
914-922 |
| 32. |
Heggeness, M. H.,
Wang, K.,
and Singer, S. J.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
3883-3887 |
| 33. |
Langanger, G.,
de Mey, J.,
Moeremans, M.,
Daneels, G.,
de Brabander, M.,
and Small, J. V.
(1984)
J. Cell Biol.
99,
1324-1334 |
| 34. |
Nunnally, M. H.,
D'Angelo, J. M.,
and Craig, S. W.
(1980)
J. Cell Biol.
87,
219-226 |
| 35. |
Schloss, J. A.,
and Goldman, R. D.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4484-4488 |
| 36. |
Mittal, B.,
Sanger, J. M.,
and Sanger, J. W.
(1987)
Cell Motil. Cytoskeleton
8,
345-359[CrossRef][Medline]
[Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
E. Y. Kim, L. D. Ridgway, and S. E. Dryer Interactions with Filamin A Stimulate Surface Expression of Large-Conductance Ca2+-Activated K+ Channels in the Absence of Direct Actin Binding Mol. Pharmacol., September 1, 2007; 72(3): 622 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marzia, R. Chiusaroli, L. Neff, N.-Y. Kim, A. H. Chishti, R. Baron, and W. C. Horne Calpain Is Required fo |